AUPQ037799A0 - Methods for diagnosing and/or predicting the risk of gastric cancer - Google Patents

Methods for diagnosing and/or predicting the risk of gastric cancer

Info

Publication number
AUPQ037799A0
AUPQ037799A0 AUPQ0377A AUPQ037799A AUPQ037799A0 AU PQ037799 A0 AUPQ037799 A0 AU PQ037799A0 AU PQ0377 A AUPQ0377 A AU PQ0377A AU PQ037799 A AUPQ037799 A AU PQ037799A AU PQ037799 A0 AUPQ037799 A0 AU PQ037799A0
Authority
AU
Australia
Prior art keywords
diagnosing
predicting
risk
methods
gastric cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ0377A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VRI Biomedical Ltd
Original Assignee
VASSE RES INST Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VASSE RES INST Pty Ltd filed Critical VASSE RES INST Pty Ltd
Priority to AUPQ0377A priority Critical patent/AUPQ037799A0/en
Publication of AUPQ037799A0 publication Critical patent/AUPQ037799A0/en
Priority to JP2000618732A priority patent/JP2002544520A/en
Priority to MXPA01011721A priority patent/MXPA01011721A/en
Priority to EP00924979A priority patent/EP1183540A4/en
Priority to CN00809065A priority patent/CN1355885A/en
Priority to AU43862/00A priority patent/AU4386200A/en
Priority to CA002372761A priority patent/CA2372761A1/en
Priority to PCT/AU2000/000441 priority patent/WO2000070348A1/en
Priority to KR1020017014533A priority patent/KR20020033093A/en
Priority to BR0010558-9A priority patent/BR0010558A/en
Assigned to VRI BIOMEDICAL PTY LTD reassignment VRI BIOMEDICAL PTY LTD Change of Name of Applicant under S 104 Assignors: VASSE RESEARCH INSTITUTE PTY LTD
Assigned to VRI BIOMEDICAL PTY LTD reassignment VRI BIOMEDICAL PTY LTD Amend patent request/document other than specification (104) Assignors: VASSE RESEARCH INSTITUTE PTY LTD
Priority to HK02106514.2A priority patent/HK1044988A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5406—IL-4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AUPQ0377A 1999-05-14 1999-05-14 Methods for diagnosing and/or predicting the risk of gastric cancer Abandoned AUPQ037799A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
AUPQ0377A AUPQ037799A0 (en) 1999-05-14 1999-05-14 Methods for diagnosing and/or predicting the risk of gastric cancer
BR0010558-9A BR0010558A (en) 1999-05-14 2000-05-15 Methods to predict and / or diagnose gastric cancer risk
MXPA01011721A MXPA01011721A (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer.
JP2000618732A JP2002544520A (en) 1999-05-14 2000-05-15 Method for predicting and / or diagnosing the risk of gastric cancer
EP00924979A EP1183540A4 (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer
CN00809065A CN1355885A (en) 1999-05-14 2000-05-15 Method for predicting and/or diagnosing risk of gastric cancer
AU43862/00A AU4386200A (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer
CA002372761A CA2372761A1 (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer
PCT/AU2000/000441 WO2000070348A1 (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer
KR1020017014533A KR20020033093A (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer
HK02106514.2A HK1044988A1 (en) 1999-05-14 2002-09-04 Methods for predicting and/or diagnosing the risk of gastric cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ0377A AUPQ037799A0 (en) 1999-05-14 1999-05-14 Methods for diagnosing and/or predicting the risk of gastric cancer

Publications (1)

Publication Number Publication Date
AUPQ037799A0 true AUPQ037799A0 (en) 1999-06-10

Family

ID=3814581

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ0377A Abandoned AUPQ037799A0 (en) 1999-05-14 1999-05-14 Methods for diagnosing and/or predicting the risk of gastric cancer

Country Status (10)

Country Link
EP (1) EP1183540A4 (en)
JP (1) JP2002544520A (en)
KR (1) KR20020033093A (en)
CN (1) CN1355885A (en)
AU (1) AUPQ037799A0 (en)
BR (1) BR0010558A (en)
CA (1) CA2372761A1 (en)
HK (1) HK1044988A1 (en)
MX (1) MXPA01011721A (en)
WO (1) WO2000070348A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ854100A0 (en) * 2000-07-03 2000-07-27 Helirad Pty Ltd Methods for monitoring treatment of helicobacter infection
GB2430031A (en) * 2005-09-07 2007-03-14 Ethicon Inc Diagnostic markers of wound infection
CN106018783A (en) * 2011-09-14 2016-10-12 巴斯夫欧洲公司 Means and methods for assessing kidney toxicity
JP6707248B2 (en) * 2013-12-05 2020-06-10 学校法人北里研究所 Gastric cancer cell detection method and gastric cancer cell detection kit
RU2706118C1 (en) * 2019-04-30 2019-11-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" Method for prediction of precancer diseases of stomach
CN117143234B (en) * 2023-08-29 2024-05-03 武汉爱博泰克生物科技有限公司 Monoclonal antibody against rat interleukin-4 protein and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012965A1 (en) * 1994-10-20 1996-05-02 Genelabs Diagnostics Pte Ltd. Helicobacter pylori diagnostic methods and kits
IT1289578B1 (en) * 1996-12-06 1998-10-15 Sanitaria Scaligera Spa IMMUNOPURIFICATION OF AN ANTIGEN WITH AN APPARENT MOLECULAR WEIGHT OF 16 + - 2 KDA OF THE HELICOBACTER PYLORI AND METHODS FOR ITS

Also Published As

Publication number Publication date
CN1355885A (en) 2002-06-26
CA2372761A1 (en) 2000-11-23
KR20020033093A (en) 2002-05-04
EP1183540A4 (en) 2007-07-04
MXPA01011721A (en) 2003-09-10
JP2002544520A (en) 2002-12-24
HK1044988A1 (en) 2002-11-08
BR0010558A (en) 2002-02-19
EP1183540A1 (en) 2002-03-06
WO2000070348A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
AU4850400A (en) The maize rs81 promoter and methods for use thereof
AU5270600A (en) The maize rs324 promoter and methods for use thereof
AU1724000A (en) Diagnostic assay for cancer
AU6754900A (en) Spectroscopic systems and methods for detecting tissue properties
AU4981299A (en) Downhole multiplexer and related methods
AU3367799A (en) Methodology for predicting and/or diagnosing disease
AU4568799A (en) Biosensor
AU6148898A (en) 2-substituted 7-haloindenes and methods for synthesizing
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU2002243549A1 (en) Diagnostic and monitoring methods for cancer
AU6468998A (en) Compositions and method for the early diagnosis of ovarian cancer
AU1602801A (en) Oilfield analysis systems and methods
AU2387900A (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU7063300A (en) Method and apparatus for predicting the risk of hypoglycemia
GB0200425D0 (en) Methods and compositions fo assaying analytes
AU2002257033A1 (en) Agents and methods for the prevention of initial onset and recurrence of existing cancers
AU3849999A (en) Endo-beta-n-acetylglucosaminidase gene
AU3760400A (en) Methods and reagents for the diagnosis and treatment of multiple sclerosis
AU2002342053A1 (en) Pancreatic cancer diagnosis and therapies
AU7363000A (en) Method for reducing the risk of cancer
AUPQ037799A0 (en) Methods for diagnosing and/or predicting the risk of gastric cancer
AU7713498A (en) Immunoassay for the detection of cancer
AU4150999A (en) Method and kit for early diagnosis of cancer
AU2002345174A1 (en) Methods for the diagnosis of cancer based on the obcam and ntm genes
AU3429300A (en) Means for diagnosing and treating carcinoma

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: VRI BIOMEDICAL PTY LTD

Free format text: FORMER NAME: VASSE RESEARCH INSTITUTE PTY LTD

NAA1 Application designating australia and claiming priority from australian document

Ref document number: 4386200

Country of ref document: AU